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CrIAGES and correlations in cytokine and eicosanoid pro-
duction by blood monocytes, non-purified and purified
peritoneal cells during a carrageenin-induced peritonitis
were investigated for a period of ten days. The cells were
isolated and stimulated in vitro. Cytokine and eicosanoid
production of the non-purified fraction increased stead-
ily during peritonitis. During the whole episode of peri-
tonitis the production capacity of granulocytes was very
low and hardly any effect on the production capacity
of macrophages (M) was observed. Cytokine and
eicosanoid production of the non-purified fraction was
mainly due to the presence ofM. The production capac-
ity of the peripheral blood monocytes was not similar to
that of the peritoneal M.
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Introduction
Inflammation is the reaction to an injury such as an
invasion by infectious agents. The blood supply to
the inflamed area increases, venular permeability
increases and leucocytes migrate out of venules into
the surrounding tissue. At the site of an acute inflam-
mation polymorphonuclear granulocytes (PMNs)
produce large amounts of reactive oxygen interme-
diates, release a variety of hydrolytic enzymes and
phagocytose pathogens. By generating chemotactic
factors, the migration of mononuclear cells
(monocytes/M and lymphocytes) to the site of in-
flammation is stimulated. ’,3 During the chronic phase
of the inflammatory response, M, mononuclear
phagocytes derived from blood monocytes, pre-
dominate over PMNs. In addition to acting as a
nonspecific defence, activated M5,6 will initiate and
control the specific defence by presenting processed
antigens to lymphocytes and by cytotoxity through
direct cell-cell contact with tumour cells or infected
cells,8,9 during which they secrete cytokines and
eicosanoids. 1,11 These inflammatory mediators also
influence and regulate functions of other cells partici-
pating in the immune response,l’a
Cytokines are proteins with regulatory functions.
They can induce other cytokines with overlapping
effects and form interactive networks with hormones
and eicosanoids. M are a potent source of a wide
variety of cytokines,4 whereas granulocytes are re-
ported to produce only a limited spectrum of
cytokines. 15-17
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Eicosanoids are bioactive lipids derived from
arachidonic acid (AA) by cyclooxygenase and
lipoxygenase pathways.8a9 Eicosa.noid production is
species and tissue dependent, and often stimulus
dependent.2,21
The aim of this work was to study cytokine
(tumour necrosis factor-m, TNF) and eicosanoid
(leukotriene B4, LTB4; prostaglandin E2, PGE2;
prostacycline, detected as 6-keto-prostaglandin Fire
6kPGF=; and thromboxane, TXB,) production capac-
ity of peritoneal PMNs, M and blood monocytes
after the induction of peritonitis with a carrageenin
solution, a sulfated polygalactan which stimulates
cell-mediated immunity.22 It was of interest to deter-
mine whether, during an episode of peritonitis,
changes occurred in (a) the differentiation of
influxed cells; (b) the cytokine and eicosanoid pro-
duction capacity of blood monocytes and peritoneal
cells; (c) interactions between different types of
peritoneal cells concerning their production capacity;
and (d) if there was a correlation between the pro-
duction of eicosanoids and TNF by blood
monocytes and peritoneal M.
Materials and Methods
Animals and treatment: Young male Wistar rats (13
weeks, approximately 200 g, six rats per group) were
injected intraperitoneally with 2 ml of a carrageenin
solution (Marine Colloids Inc., USA, 1 mg/ml) on day
0. Six rats received an injection of saline (control
group).
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Cell isolation: On day 1 (that is, 24 h after inducing
the peritonitis with the carrageenin solution), three,
seven and ten peritoneal cells and monocytes from
the blood were isolated. With each group, cells were
also isolated from a control animal, which was con-
sidered as day 0. Blood (_+ 7 ml) was collected in
tubes with 1 ml EDTA (0.1 M) after decapitation. The
blood was centrifuged (400 xg, 4C, 10 min) and
from the leucocyte layer the monocytes were isolated
into a ’monocyte’ fraction by density gradient
centrifugation using Percoll (d 1.064 g/ml,
Kabi-Pharmacia, Sweden; 400xg, 4C, 25 min).
Monocytes were washed three times with phosphate
buffer solution (PBS, 400 xg, 4C, 10 min) and sus-
pended in Dulbecco’s modification of Eagle’s me-
dium (DMEM + HEPES (GIBCO, UK)+ penicillin/
streptomycin (5 x 10 U/1 per 50 mg/1, Flow Lab,
UK) + foetal calf serum (10% FCS, GIBCO, UK) + L-
glutamine (600 mg/1 Flow Lab, UK), 1 x 106 cells/ml).
The peritoneal cavities, were washed twice with
20 ml PBS (pH 7.4, 4C, Oxoid, UK). The washings
per rat were pooled, centrifuged (400 xg, 4C, 10
min) and suspended in 5 ml DMEM. 5 x 106 cells of
this non-purified fraction were kept separate, the rest
of this ’crude’ fraction was separated on Percoll into
a ’macrophage’ and a ’granulocyte’ fraction. These
two purified fractions were washed three times with
PBS (400 xg, 4C, 10 min), and suspended in DMEM
(i x 106 cells/ml).
A small sample of cells from each fraction was
stained by Hemacolor (Merck, Germany) and the
different cell types were counted using a microscope
(Zeiss, standard 25, Germany). The viability of the
cells was determined by trypan blue exclusion.
Cell incubation: One million leucocytes per ml
DMEM were plated on plastic culture dishes (Costar,
UK). The cells were triggered for 15 min by calcium
ionophore A23187 (Calbiochem, USA), 1 t.tM final
concentration in dimethylsulfoxide (0.1% DMSO,
Sigma, USA), 37C, 7.5% CO,.). Controls were incu-
bated with DMSO (0.1%).
The cells were also incubated for 24 h in the
absence or presence of lipopolysaccharide (LPS,
10 l.tg/ml final concentration in PBS, LPS from E. coli
0111:B4 in PBS (Sigma, USA), 37C, 7.5% COg). As a
blank, PBS was added. At the end of the incubation
the supernatant was centrifuged and kept at -80C
until required for analysis.
Cytokine production: TNFc production in the sam-
ples was determined directly in the supernatant by
bioassay. For this bioassay the TNF0t sensitive cell
line WEHI-164 was used. The WEHI-164 cells were
plated out in 96-well plates (2 x 10 cells/50 btl/well,
Costar, UK) and the samples (50 l.d/well) or the
human recombinant TNFz (hr-TNFc) standards
(0.1-1000u/ml hr-TNFc, 50 l.d/well) were added.
After 24h incubation (37C, 7.5% CO2), MTT
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(tetrazolium salt, Sigma, USA) was added (0.125 mg/
well) and after an incubation of 3 h the cells were
lysed with buffer (20% sodium dodecyl sulfate (SDS)
in 50% N,N-dimethylformamide (DMF), pH 4.7,
100 l.d/well) for 18 h. The absorbance was measured
at 595 nm with an ELISA reader (BIO-RAD, model
3550, UK). The TNFz production by the Me was
expressed as the cytotoxicity against WEHI-164 cells
compared to the blank (DMEM complete).23
Eicosanoid production: Eicosanoid production
(LTB4, PGE2, TXB2 and 6kPGFI= from endogenous
arachidonate of the samples was determined directly
in the supernatant by radioimmuno assays (antibod-
ies were obtained from Advanced Magnetics, USA;
standards from Sigma, USA; and tritiated antigens
from Amersham, UK). Cross-reactivities for individual
antigens on antibodies were negligible.
Statistical analysis: Data are expressed as the mean
_+ standard error of the mean (S.E.M.). Data were
analysed statistically with ANOVA followed by the
Dunnett test or Student’s t-test. The correlations were
determined by the Pearson Correlation test. Data
were considered significant when p < 0.05.
Results
Concentration and differentiation of cells obtained
from theperitoneal cavity. Induction of peritonitis in
rats caused an increase of cells in the peritoneal
cavity on day 1. The cell count dropped on the
following days (Fig. 1A). A pronounced influx of
granulocytes was seen on the first day which was
followed by an influx of Me, resulting in a Me/
granulocyte ratio of 4:1 from day 3 to 10 (Fig. 1B).
Production capacity of cells to generate inflamma-
tory mediators: The inflammatory mediator produc-
tion per million cells stimulated in vitro (LTB4, 15 min
A23187; and PGE2, TXB2, 6kPGFI=, TNFo:, 24 h LPS)
by the peritoneal ’crude’, ’macrophage’ and
’granulocyte’ fractions and the peripheral blood
’monocyte’ fraction is shown in Fig. 2A, 2B, 2C and
2D.
Cytokine and eicosanoid production by the crude
fraction increased steadily during peritonitis. TNFc
and TXB2 reached peak levels after 3 days, whereas
PGE2 and 6kPGFI= reached a plateau 7 days after
induction of the peritonitis. In comparison with lev-
els of other eicosanoids the LTB4 production was low
before and on the first day of the peritonitis and
decreased significantly thereafter. By day 10 the pro-
duction capacity returned to the initial level.
The production pattern of the cells from the
macrophage fraction (Fig. 2B) was similar to that of
cells from the crude fraction (Fig. 2A). Inflammatory
mediators were also produced by the granulocyte
fraction (Fig. 2C), although the production capacity
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FIG. 1. Time course (0-10 days) of cell number (A) and differentiation of the cells (B) during a peritonitis in rats. M (e); granulocytes (e). Mean + S.E.M.;
n 6 per group; *p < 0.05 macrophages vs. granulocytes.
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FIG. 2. Production capacity of stimulated ’crude’ (A), ’macrophage’ (B), ’granulocyte’ (C) and ’monocyte’ (D) fraction to produce the eicosanoids LTB (+);
PGE (,); 6kPGFI (e); TXB2 (B); and the cytokine TNFx (e). LTB4 production of 10cells/ml determined in supernatant after 15 min, IM A23187
stimulation. PGEv TXBv 6kPGFI, TNF(x production of 106 cells/ml determined in supernatant after 24 h 10 lg/ml LPS stimulation; mean + S.E.M.;",#,= p < 0.05
vs. day 0; n 4-6.
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of these cells was very low in comparison with cells
from the crude and macrophage fraction. The pattern
of inflammatory mediator production of the
granulocyte fraction did not significantly change in
time. On the tenth day after induction of the perito-
nitis, the concentration of the cells in the granulocyte
fraction was too low to permit in vitro incubations.
The capacity of cells from the peripheral blood
monocyte fraction to produce inflammatory media-
tors (Fig. 2D) was at least four times lower in com-
parison with both the crude and macrophage frac-
tions. The production capacity of the cells from the
monocyte fraction was about the same with or with-
out stimulus. The patterns of the TNFz, PGE and
6kPGFI= production of cells from the monocyte frac-
tion were different from those of the macrophage
and crude fraction. After induction of peritonitis
the TNF0t production of cells from the monocyte
fraction increased significantly only on the tenth day,
whereas PGE2 and TXB,. reached their highest
level on the third day. The 6kPGFlu level did not
change during peritonitis. The LTB4 production was
negligible.
Correlations between inflammatory mediators pro-
duced in the samefraction: In the crude fraction (Fig.
2A) there was a significant positive correlation be-
tween the production of PGE,. and 6kPGFI= and PGE2
and TXB,. (r= 0.6365 and r= 0.7145). Similar signifi-
cant correlations were found in the macrophage
fraction (Fig. 2B, r= 0.5580 and r= 0.6106). In the
monocyte fraction (Fig. 2D) the only significant posi-
tive correlation between the inflammatory mediators
was between PGE and WXB (r= 0.8881).
Correlation between inflammatory mediators in
different fractions: In Fig. 2A and 2B the patterns
of inflammatory mediators produced by the stimu-
lated crude and macrophage cell fractions are pre-
sented. There was always a significant positive
correlation between these two fractions. The corre-
lation varied from r= 0.5671 for LTB to r 0.8586 for
TNFo:. (PGE,., r= 0.6254; 6kPGFI=, r= 0.7536; and
TXB2, r= 0.7502). This correlation remained signifi-
cant when we assumed that production of the cell
inflammation mediators in the crude and
macrophage fraction were only derived from the Me
(calculated to 100% macrophages, LTB4=0.4649;
PGE2 0.5855; 6kPGFI= 0.5506; TXB2 0.7810; and
TNFo: 0.8674).
There were, however, some significant differences
between the calculated (to 100% Me) production
levels of the crude and macrophage fractions. When
separate days were considered the production levels
of the calculated crude fraction in comparison with
the calculated macrophage fraction was on day 1
lower for PGE2 and 6kPGF=, and on day 3 higher for
gWB4, TXB2 and TNFo: (Fig. 3 A-E).
Correlation coefficient between inflammatory media-
torsfrom monocyte and macrophagefraction: Only
the basal TNFz production of the cells from the
monocyte and macrophage fraction were clearly
correlated (r= 0.5421).
Discussion
Characterization of inflammatory mediators pro-
duced by granulocytes and monocytes/macrophages
during induced inflammation in animal models, may
be helpful to the understanding of inflammatory
diseases and their treatment. The present study in-
vestigated the changes and correlations in cytokine
and eicosanoid production capacity of peripheral
blood monocytes, non-purified (’crude’ fraction) and
purified (’macrophage’ and ’granulocyte’ fraction)
peritoneal cells during a carrageenin-induced perito-
nitis in rats.
In the present study, where an influx of leucocytes
into the peritoneum was achieved after carrageenin
injection, the number of PMNs increased in the acute
phase (day 1) and thereafter decreased quickly. On
day 0, before inducing the peritonitis, there was a
reasonable number of Me present in the peritoneal
cavity. The number of Me increased from day 1 until
7 days after induction of the peritonitis, resulting in
a mainly Me cell population. Previous histological
studies had similar results,’4,25 although a quantitative
and kinetic method showed that both monocytes
and PMNs from rat migrate rapidly to the inflamed
site, the migration of PMNs, however, also declined
long before the migration of monocytes started to
decrease. The pattern of this migration can be
explained with the function of the leucocytes in
inflammation. In the initial phase both PMNs and Me
are involved in nonspecific defence mechanisms.,2
In addition, Me will also initiate and control the
specific defence.7-1 The mechanism of this selective
migration is not clear. Leucocyte adhesion to
the blood vessel endothelium, which is followed
by transendothelial migration, is a multistep
process in which several adhesion molecules are
involved, z6,z7
Our experiment showed that the inflammatory
mediator production capacity of the non-purified
fraction, which was harvested from the inflamed
peritoneal cavity, changed with time. The production
of inflammatory mediators in the non-purified frac-
tion was mainly caused by the presence of M) during
carrageenin-induced peritonitis. This is, first of all,
based on the significant correlation between the
eicosanoid and TNFot production capacity of the
macrophage fraction and the crude fraction, these
correlations hardly changed when it was assumed
that these fractions only contained M. Secondly, the
production capacity of the granulocytes appeared to
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FIG. 3. Production capacity of the stimulated ’crude’ (B) and ’macrophage’ fraction (e) (calculated to 100% M) to produce the eicosanoids LTB (A), PGE
(B), 6kPGFI (C), TXB2 (D) and the cytokine TNFo (E). LTB production of 106 cells/ml determined in supernatant after 15 min, IM A23187 stimulation.
PGE, TXB, 6kPGFI, TNFo production of 106 cells/ml determined in supernatant after 24 h 10 g/ml LPS stimulation; mean +_ S.E.M.; "p < 0.05 vs. day 0;
"p < 0.05 granulocytes vs. macrophages; n 4-6.
be very low. Moreover the production capacity of the
granulocyte fraction did not correlate with the crude
fraction.
When the production levels of the non-purified
fraction was compared with the macrophage fraction,
assuming that the inflammatory mediators were only
produced by M, it was observed that the production
of PGE,. and 6kPGFI= had decreased on day I and the
production of LTB4, TXB and TNF had increased
on day 3. The results of these effects could be an
amplification of the inflammation, due to the de-
crease of anti-inflammatory substances and the sub-
sequent increase of pro-inflammatory substances.
The low production capacity of the crude fraction
in the acute phase followed by an increasing produc-
tion capacity in the chronic phase could also be
explained by presence of the M. Blood monocytes
and resident M transform from primed into active
M at the side of the inflammation, after which
profound changes occur in morphology and function
of these cells. The M present at day 1 in the
peritoneal cavity, probably were not primed in vivo
at this time, which could be the reason that the
eicosanoid and cytokine production capacity of
these M were so low after stimulation in vitro with
LPS. Once these M were primed in vivo, also the
new monocytes that migrate into the peritoneal cav-
ity, the production capacity of these monocytes/M
steadily increased, showing in vitro a differentiated
pattern for the eicosanoids and TNF. This pattern
probably depends on the function of the metabolite.
As peripheral blood monocytes transform into
peritoneal m, the correlation between these cells
was investigated. The eicosanoid and TNF produc-
tion capacity of blood monocytes was not similar to
that of M during peritonitis. It was clearly shown
that through influx and transformation of monocytes
into M the synthesis of mediators completely
changed.
In conclusion, M are the main source of the
inflammatory mediators whose production is de-
pendent on the episode of the carrageenin-induced
peritonitis.Characterization of purified M in vitro in
animal and human models will be helpful to the
understanding of inflammatory diseases and their
treatment. Peripheral blood monocytes do not reflect
mediator production ofM present at the inflamma-
tory site.
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